Effect of gemigliptin on glycaemic variability in patients with type 2 diabetes (STABLE study).
about
A randomized controlled trial comparing the effects of dapagliflozin and DPP-4 inhibitors on glucose variability and metabolic parameters in patients with type 2 diabetes mellitus on insulin.Gemigliptin: Newer Promising Gliptin for Type 2 Diabetes Mellitus.Potentiation of endothelium-dependent vasorelaxation of mesenteric arteries from spontaneously hypertensive rats by gemigliptin, a dipeptidyl peptidase-4 inhibitor class of anti-diabetic drug
P2860
Effect of gemigliptin on glycaemic variability in patients with type 2 diabetes (STABLE study).
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Effect of gemigliptin on glyca ...... ype 2 diabetes (STABLE study).
@en
Effect of gemigliptin on glycaemic variability in patients with type 2 diabetes
@nl
type
label
Effect of gemigliptin on glyca ...... ype 2 diabetes (STABLE study).
@en
Effect of gemigliptin on glycaemic variability in patients with type 2 diabetes
@nl
prefLabel
Effect of gemigliptin on glyca ...... ype 2 diabetes (STABLE study).
@en
Effect of gemigliptin on glycaemic variability in patients with type 2 diabetes
@nl
P2093
P2860
P356
P1476
Effect of gemigliptin on glyca ...... type 2 diabetes (STABLE study)
@en
P2093
Byung W Lee
Chang H Jung
Gwong C Hur
STABLE Study Group
Seung H Lee
Sung H Kim
P2860
P304
P356
10.1111/DOM.12869
P577
2017-03-16T00:00:00Z